International audienceThe slow inward Ca2+ current, ICa, is fundamental in the initiation of cardiac contraction and neurohormonal regulation of cardiac function. It is increased by beta-adrenergic agonists, which stimulate synthesis of cyclic AMP (cAMP) and cAMP-dependent phosphorylation. The neurotransmitter acetylcholine reduces ICa by an unknown mechanism. There is strong evidence that acetylcholine reduces ICa by decreasing adenylate cyclase activity, but cGMP has also been implicated as ACh stimulates cGMP accumulation and activates cGMP-dependent protein kinase. Application of cGMP decreases contractile force, decreases Ca flux, shortens the duration of action potentials and inhibits Ca-dependent action potentials. Other studies, how...
International audience1. Ca currents (ICa) were measured by whole-cell patch clamp in single cells i...
RATIONALE: cAMP and cGMP are intracellular second messengers involved in heart pathophysiology. cGMP...
RATIONALE: cAMP and cGMP are intracellular second messengers involved in heart pathophysiology. cGMP...
International audienceRegulation of cardiac contraction by neurotransmitters and hormones is often c...
International audience1. The effect of intracellular perfusion with cyclic AMP and cyclic GMP on Ca2...
It has previously been shown that intracellular perfusion of isolated cardiac myocytes with cGMP red...
The cardiac L-type Ca2+ channel current (ICa) is an important determinant of myocardial contractilit...
The cardiac L-type Ca2+ channel current (ICa) is an important determinant of myocardial contractilit...
EHNA (Erythro-9-[2-hydroxy-3-nonyl]adenine) is a wellknown inhibitor of adenosine deaminase. Recentl...
Cyclic nucleotide phosphodiesterases regulate cAMP-mediated signaling by controlling intracellular c...
International audienceEHNA (Erythro-9-[2-hydroxy-3-nonyl]adenine) is a wellknown inhibitor of adenos...
cAMP and cGMP signalling pathways are common targets in the pharmacological treatment of heart failu...
International audience1. The regulation of the L-type Ca(2+) current (I(Ca)) by intracellular cGMP w...
cAMP and cGMP signalling pathways are common targets in the pharmacological treatment of heart failu...
Rationale: cAMP and cGMP are intracellular second messengers involved in heart pathophysiology. cGMP...
International audience1. Ca currents (ICa) were measured by whole-cell patch clamp in single cells i...
RATIONALE: cAMP and cGMP are intracellular second messengers involved in heart pathophysiology. cGMP...
RATIONALE: cAMP and cGMP are intracellular second messengers involved in heart pathophysiology. cGMP...
International audienceRegulation of cardiac contraction by neurotransmitters and hormones is often c...
International audience1. The effect of intracellular perfusion with cyclic AMP and cyclic GMP on Ca2...
It has previously been shown that intracellular perfusion of isolated cardiac myocytes with cGMP red...
The cardiac L-type Ca2+ channel current (ICa) is an important determinant of myocardial contractilit...
The cardiac L-type Ca2+ channel current (ICa) is an important determinant of myocardial contractilit...
EHNA (Erythro-9-[2-hydroxy-3-nonyl]adenine) is a wellknown inhibitor of adenosine deaminase. Recentl...
Cyclic nucleotide phosphodiesterases regulate cAMP-mediated signaling by controlling intracellular c...
International audienceEHNA (Erythro-9-[2-hydroxy-3-nonyl]adenine) is a wellknown inhibitor of adenos...
cAMP and cGMP signalling pathways are common targets in the pharmacological treatment of heart failu...
International audience1. The regulation of the L-type Ca(2+) current (I(Ca)) by intracellular cGMP w...
cAMP and cGMP signalling pathways are common targets in the pharmacological treatment of heart failu...
Rationale: cAMP and cGMP are intracellular second messengers involved in heart pathophysiology. cGMP...
International audience1. Ca currents (ICa) were measured by whole-cell patch clamp in single cells i...
RATIONALE: cAMP and cGMP are intracellular second messengers involved in heart pathophysiology. cGMP...
RATIONALE: cAMP and cGMP are intracellular second messengers involved in heart pathophysiology. cGMP...